Klotho Neurosciences (KLTO) Competitors $0.58 -0.01 (-2.33%) As of 09:34 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock KLTO vs. DERM, CCCC, CYBN, CRBU, TNYA, SXTC, FTLF, MEIP, TVGN, and MCRBShould you be buying Klotho Neurosciences stock or one of its competitors? The main competitors of Klotho Neurosciences include Journey Medical (DERM), C4 Therapeutics (CCCC), Cybin (CYBN), Caribou Biosciences (CRBU), Tenaya Therapeutics (TNYA), China SXT Pharmaceuticals (SXTC), FitLife Brands (FTLF), MEI Pharma (MEIP), Tevogen Bio (TVGN), and Seres Therapeutics (MCRB). These companies are all part of the "pharmaceutical products" industry. Klotho Neurosciences vs. Its Competitors Journey Medical C4 Therapeutics Cybin Caribou Biosciences Tenaya Therapeutics China SXT Pharmaceuticals FitLife Brands MEI Pharma Tevogen Bio Seres Therapeutics Klotho Neurosciences (NASDAQ:KLTO) and Journey Medical (NASDAQ:DERM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment. Do insiders & institutionals hold more shares of KLTO or DERM? 20.1% of Klotho Neurosciences shares are owned by institutional investors. Comparatively, 7.3% of Journey Medical shares are owned by institutional investors. 26.7% of Klotho Neurosciences shares are owned by company insiders. Comparatively, 15.0% of Journey Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to KLTO or DERM? In the previous week, Journey Medical had 3 more articles in the media than Klotho Neurosciences. MarketBeat recorded 3 mentions for Journey Medical and 0 mentions for Klotho Neurosciences. Journey Medical's average media sentiment score of 0.99 beat Klotho Neurosciences' score of 0.00 indicating that Journey Medical is being referred to more favorably in the news media. Company Overall Sentiment Klotho Neurosciences Neutral Journey Medical Positive Which has preferable valuation & earnings, KLTO or DERM? Klotho Neurosciences has higher earnings, but lower revenue than Journey Medical. Journey Medical is trading at a lower price-to-earnings ratio than Klotho Neurosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKlotho NeurosciencesN/AN/A-$6.15M-$0.45-1.31Journey Medical$56.13M3.02-$14.67M-$0.38-18.29 Which has more risk and volatility, KLTO or DERM? Klotho Neurosciences has a beta of 10.74, meaning that its stock price is 974% more volatile than the S&P 500. Comparatively, Journey Medical has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Is KLTO or DERM more profitable? Klotho Neurosciences has a net margin of 0.00% compared to Journey Medical's net margin of -15.49%. Journey Medical's return on equity of -48.69% beat Klotho Neurosciences' return on equity.Company Net Margins Return on Equity Return on Assets Klotho NeurosciencesN/A -325.88% -242.15% Journey Medical -15.49%-48.69%-11.26% Do analysts rate KLTO or DERM? Journey Medical has a consensus target price of $12.17, suggesting a potential upside of 75.06%. Given Journey Medical's stronger consensus rating and higher possible upside, analysts clearly believe Journey Medical is more favorable than Klotho Neurosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Klotho Neurosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Journey Medical 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryJourney Medical beats Klotho Neurosciences on 9 of the 15 factors compared between the two stocks. Get Klotho Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLTO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KLTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLTO vs. The Competition Export to ExcelMetricKlotho NeurosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$42.58M$2.50B$5.77B$9.72BDividend YieldN/A48.51%6.66%4.49%P/E Ratio-1.3122.6482.6126.60Price / SalesN/A543.46504.06158.88Price / CashN/A26.3325.7028.92Price / Book3.466.7910.876.56Net Income-$6.15M$32.94M$3.28B$266.04M7 Day Performance-18.70%0.80%0.10%-0.89%1 Month Performance-41.01%6.13%8.93%4.34%1 Year PerformanceN/A-0.23%51.11%24.06% Klotho Neurosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLTOKlotho NeurosciencesN/A$0.58-2.3%N/AN/A$35.31MN/A-1.28N/AGap DownDERMJourney Medical1.8336 of 5 stars$7.42+0.3%$12.17+64.0%+45.1%$180.40M$56.13M0.0090CCCCC4 Therapeutics1.6855 of 5 stars$2.57+1.6%$8.00+211.3%-57.4%$180.06M$35.58M0.00150News CoverageAnalyst ForecastGap UpCYBNCybin1.9162 of 5 stars$7.45+2.8%$85.00+1,040.9%N/A$175.75MN/A-1.7050Gap UpCRBUCaribou Biosciences2.0318 of 5 stars$2.00+6.4%$6.67+233.3%-4.5%$175.07M$9.99M0.00100TNYATenaya Therapeutics2.9585 of 5 stars$1.08+0.9%$6.25+478.7%-53.4%$174.38MN/A-1.13110Analyst ForecastSXTCChina SXT PharmaceuticalsN/A$1.48flatN/A-70.8%$171.72M$1.74M0.0090Gap UpFTLFFitLife Brands3.3481 of 5 stars$18.43+1.3%$22.00+19.4%+3.2%$170.96M$64.47M21.0520MEIPMEI Pharma0.9787 of 5 stars$5.28+5.6%N/A+46.6%$170.91M$65.30M-1.11100TVGNTevogen Bio3.5405 of 5 stars$0.92+0.1%$10.00+985.8%+89.0%$169.37MN/A0.003Analyst ForecastShort Interest ↑MCRBSeres Therapeutics3.144 of 5 stars$19.35+0.6%$73.67+280.7%+18.1%$169.31M$126.32M-4.21330 Related Companies and Tools Related Companies Journey Medical Competitors C4 Therapeutics Competitors Cybin Competitors Caribou Biosciences Competitors Tenaya Therapeutics Competitors China SXT Pharmaceuticals Competitors FitLife Brands Competitors MEI Pharma Competitors Tevogen Bio Competitors Seres Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLTO) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Klotho Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Klotho Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KLTO Stock Alerts